FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968606710> ?p ?o ?g. }

• W2968606710 endingPage "106451" @default.
• W2968606710 startingPage "106451" @default.
• W2968606710 abstract "Despite the approval of a considerable number of last generation antiepileptic drugs (AEDs) (only in the last decade, six drugs have gained Food and Drug Administration approval), the global figures of seizure control have seemingly not improved, and available AED can still be regarded as symptomatic treatments. Fresh thinking in AEDs drug discovery, including the development of drugs with novel mechanisms of action, is required to achieve truly innovative antiepileptic medications. The transporter hypothesis proposes that inadequate penetration of AEDs across the blood–brain barrier, caused by increased expression of efflux transporters such as P-glycoprotein (P-gp), contributes to drug-resistant epilepsy. Neuroinflammation due to high levels of glutamate has been identified as one of the causes of P-gp upregulation, and several studies in animal models of epilepsy suggest that antiinflammatory drugs might prevent P-gp overexpression and, thus, avoid the development of refractory epilepsy. We have applied ligand-based in silico screening to select compounds that exert dual anticonvulsant and antiinflammatory effects. Five of the hits were tested in animal models of seizure, with protective effects. Later, two of them (sebacic acid (SA) and gamma-decanolactone) were submitted to the recently described MP23 model of drug-resistant seizures. All in all, SA displayed the best profile, showing activity in the maximal electroshock seizure (MES) and pentylenetetrazol (PTZ) seizure models, and reversing resistance to phenytoin (PHT) and decreasing the P-gp upregulation in the MP23 model. Furthermore, pretreatment with SA in the pilocarpine status epilepticus (SE) model resulted in decreased histamine release in comparison with nontreated animals. This is the first report of the use of the MP23 model to screen for novel anticonvulsant compounds that may avoid the development of P-gp-related drug resistance." @default.
• W2968606710 created "2019-08-22" @default.
• W2968606710 creator A5002140696 @default.
• W2968606710 creator A5023672893 @default.
• W2968606710 creator A5043993491 @default.
• W2968606710 creator A5050261191 @default.
• W2968606710 creator A5052585017 @default.
• W2968606710 creator A5062436479 @default.
• W2968606710 creator A5074323215 @default.
• W2968606710 creator A5088644153 @default.
• W2968606710 creator A5091752028 @default.
• W2968606710 date "2021-08-01" @default.
• W2968606710 modified "2023-10-15" @default.
• W2968606710 title "New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in mice" @default.
• W2968606710 cites W1554576051 @default.
• W2968606710 cites W1571439140 @default.
• W2968606710 cites W1705576088 @default.
• W2968606710 cites W1898035317 @default.
• W2968606710 cites W1963512151 @default.
• W2968606710 cites W1967028602 @default.
• W2968606710 cites W1968319881 @default.
• W2968606710 cites W1970117905 @default.
• W2968606710 cites W1973120027 @default.
• W2968606710 cites W1974240614 @default.
• W2968606710 cites W1976206458 @default.
• W2968606710 cites W1996851544 @default.
• W2968606710 cites W1998056319 @default.
• W2968606710 cites W1998290119 @default.
• W2968606710 cites W1999985301 @default.
• W2968606710 cites W2004872765 @default.
• W2968606710 cites W2014276094 @default.
• W2968606710 cites W2018532368 @default.
• W2968606710 cites W2024578140 @default.
• W2968606710 cites W2030963350 @default.
• W2968606710 cites W2036844214 @default.
• W2968606710 cites W2038026687 @default.
• W2968606710 cites W2043773337 @default.
• W2968606710 cites W2058159881 @default.
• W2968606710 cites W2060540729 @default.
• W2968606710 cites W2060609738 @default.
• W2968606710 cites W2061473666 @default.
• W2968606710 cites W2071360587 @default.
• W2968606710 cites W2074681440 @default.
• W2968606710 cites W2077355747 @default.
• W2968606710 cites W2078461915 @default.
• W2968606710 cites W2090276138 @default.
• W2968606710 cites W2094733995 @default.
• W2968606710 cites W2103800437 @default.
• W2968606710 cites W2121434426 @default.
• W2968606710 cites W2137052779 @default.
• W2968606710 cites W2139154816 @default.
• W2968606710 cites W2151704105 @default.
• W2968606710 cites W2156900818 @default.
• W2968606710 cites W2161208527 @default.
• W2968606710 cites W2163754658 @default.
• W2968606710 cites W2163967054 @default.
• W2968606710 cites W2300160852 @default.
• W2968606710 cites W2328176404 @default.
• W2968606710 cites W2483704830 @default.
• W2968606710 cites W2539266343 @default.
• W2968606710 cites W2543998557 @default.
• W2968606710 cites W2587084013 @default.
• W2968606710 cites W2594013298 @default.
• W2968606710 cites W2726666234 @default.
• W2968606710 cites W4293247451 @default.
• W2968606710 doi "https://doi.org/10.1016/j.yebeh.2019.106451" @default.
• W2968606710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31420290" @default.
• W2968606710 hasPublicationYear "2021" @default.
• W2968606710 type Work @default.
• W2968606710 sameAs 2968606710 @default.
• W2968606710 citedByCount "15" @default.
• W2968606710 countsByYear W29686067102020 @default.
• W2968606710 countsByYear W29686067102021 @default.
• W2968606710 countsByYear W29686067102022 @default.
• W2968606710 countsByYear W29686067102023 @default.
• W2968606710 crossrefType "journal-article" @default.
• W2968606710 hasAuthorship W2968606710A5002140696 @default.
• W2968606710 hasAuthorship W2968606710A5023672893 @default.
• W2968606710 hasAuthorship W2968606710A5043993491 @default.
• W2968606710 hasAuthorship W2968606710A5050261191 @default.
• W2968606710 hasAuthorship W2968606710A5052585017 @default.
• W2968606710 hasAuthorship W2968606710A5062436479 @default.
• W2968606710 hasAuthorship W2968606710A5074323215 @default.
• W2968606710 hasAuthorship W2968606710A5088644153 @default.
• W2968606710 hasAuthorship W2968606710A5091752028 @default.
• W2968606710 hasConcept C104317684 @default.
• W2968606710 hasConcept C114851261 @default.
• W2968606710 hasConcept C118552586 @default.
• W2968606710 hasConcept C127561419 @default.
• W2968606710 hasConcept C133936738 @default.
• W2968606710 hasConcept C185592680 @default.
• W2968606710 hasConcept C2775858608 @default.
• W2968606710 hasConcept C2776749334 @default.
• W2968606710 hasConcept C2776819090 @default.
• W2968606710 hasConcept C2777332695 @default.
• W2968606710 hasConcept C2777341932 @default.
• W2968606710 hasConcept C2778186239 @default.
• W2968606710 hasConcept C2778337148 @default.

• next